Activation of β2-adrenergic receptor signals inhibit progression of oral cancer by suppressing mesenchymal phenotypes (IMAGE)
Caption
In this study we identified isoxsuprine, a β2-adrenergic receptor agonist as an effective inhibitor of mesenchymal phenotypes and migration of oral squamous cell carcinoma cells suggesting that β2-adrenergic receptor signal is a new promising therapeutic target for treatment of oral cancer.
Credit
Department of Biochemistry,TMDU
Usage Restrictions
None
License
Licensed content